Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Depreciation & Amortization (CF) (2019 - 2023)

Historic Depreciation & Amortization (CF) for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to $335000.0.

  • ADC Therapeutics' Depreciation & Amortization (CF) fell 6837.33% to $335000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year increase of 1198.11%. This contributed to the annual value of $1.3 million for FY2024, which is 1238.42% up from last year.
  • Per ADC Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $335000.0 for Q4 2023, which was down 6837.33% from $316000.0 recorded in Q3 2023.
  • Over the past 5 years, ADC Therapeutics' Depreciation & Amortization (CF) peaked at $1.1 million during Q4 2022, and registered a low of $88.0 during Q3 2019.
  • In the last 5 years, ADC Therapeutics' Depreciation & Amortization (CF) had a median value of $258.5 in 2022 and averaged $171133.1.
  • As far as peak fluctuations go, ADC Therapeutics' Depreciation & Amortization (CF) tumbled by 9988.24% in 2021, and later skyrocketed by 12579641.43% in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' Depreciation & Amortization (CF) stood at $195.0 in 2019, then skyrocketed by 75797.44% to $148000.0 in 2020, then plummeted by 99.84% to $230.0 in 2021, then skyrocketed by 460435.65% to $1.1 million in 2022, then tumbled by 68.37% to $335000.0 in 2023.
  • Its Depreciation & Amortization (CF) was $335000.0 in Q4 2023, compared to $316000.0 in Q3 2023 and $273000.0 in Q2 2023.